Introduction
- Urokinase is a fibrinolytic (thrombolytic) drug used to dissolve blood clots.
- It was originally isolated from human urine (hence its name) but is now produced from human kidney cell cultures.
- It plays a critical role in emergency medicine, especially in treating life-threatening blood clots.
Mechanism of Action
- Urokinase is a serine protease enzyme.
- It works by converting plasminogen → plasmin, the active enzyme that breaks down fibrin, the main structural protein in blood clots.
- This results in clot dissolution and restored blood flow.
Clinical Uses
1. Pulmonary Embolism (PE) – dissolves clots in the lungs.
2. Deep Vein Thrombosis (DVT) – restores venous circulation.
3. Catheter Clearance – used in small doses to clear occluded IV catheters.
4. Off-label: sometimes considered for peripheral arterial occlusion and other thrombotic conditions.
Dosage & Administration
- Administered intravenously under close monitoring.
- Dosing depends on indication (e.g., higher for PE, lower for catheter clearance).
- Continuous infusion is often used for systemic thrombolysis.
Advantages
- Direct plasminogen activator (unlike streptokinase, it does not require a cofactor).
- Human-derived → lower risk of allergic reactions compared to bacterial products like streptokinase.
- Effective in dissolving fresh clots rapidly.
Risks & Side Effects
- Major risk: bleeding (intracranial hemorrhage, gastrointestinal bleeding).
- Hypotension and fever may occur.
- Contraindications: recent surgery, active bleeding, history of hemorrhagic stroke, uncontrolled hypertension.
Life-Saving Impact
- By restoring blood flow in blocked vessels, urokinase can prevent tissue death, organ failure, and fatal complications.
- It has been especially valuable in massive pulmonary embolism, where rapid clot removal is crucial.
Conclusion
Urokinase remains a vital thrombolytic agent in clinical practice.
Its ability to rapidly dissolve blood clots makes it a life-saving intervention in emergencies, though careful patient selection and monitoring are essential to balance the benefits with the risk of bleeding.






